| Literature DB >> 33077748 |
Matthew A Dixon1,2, Peter Winskill3, Wendy E Harrison4, Charles Whittaker3, Veronika Schmidt5,6, Elsa Sarti7, Saw Bawm8, Michel M Dione9, Lian F Thomas10,11, Martin Walker12, Maria-Gloria Basáñez13,3.
Abstract
The World Health Organization (WHO) called, in 2012, for a validated strategy towards Taenia solium taeniasis/cysticercosis control and elimination. Estimating pig force-of-infection (FoI, the average rate at which susceptible pigs become infected) across geographical settings will help understand local epidemiology and inform effective intervention design. Porcine cysticercosis (PCC) age-prevalence data (from 15 studies in Latin America, Africa and Asia) were identified through systematic review. Catalytic models were fitted to the data using Bayesian methods, incorporating uncertainty in diagnostic performance, to estimate rates of antibody seroconversion, viable metacestode acquisition, and seroreversion/infection loss. There was evidence of antibody seroreversion across 5 studies, and of infection loss in 6 studies measured by antigen or necropsy, indicating transient serological responses and natural resolution of infection. Concerted efforts should be made to collect robust data using improved diagnostics to better understand geographical heterogeneities in T. solium transmission to support post-2020 WHO targets.Entities:
Mesh:
Year: 2020 PMID: 33077748 PMCID: PMC7572398 DOI: 10.1038/s41598-020-74007-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Simple and reversible catalytic model structure and equations of the models fitted to data on the age (a)-specific (sero)prevalence (p(a)), where λ is the force-of-infection (rate of seroconversion or infection acquisition) and ρ the rate of seroreversion or infection loss. The general mathematical form of the catalytic models fitted to the antibody (first equation in 1a and 1b), antigen and necropsy prevalence (second equation in 1a and 1b) datasets to estimate the prevalence (p) at pig age (a). Setting a0 = 0 yields the non-truncated model variant and setting ρ = 0 yields the non-reversible, simple catalytic model. The saturating (sero)prevalence is given by λ/(λ + ρ) which for the simple model is 100%, if the pigs lived sufficiently long. The accompanying tables provide information on the definitions of the catalytic model parameters depending on the diagnostic method used to detect positivity.
Seroprevalence and parameter estimates for the best-fit catalytic models fitted to each observed antibody age-seroprevalence dataset (ordered by decreasing all-age seroprevalence).
| Dataset, country | All-age observed sero-prevalence (%) | Best-fit catalytic model | Diagnostic sensitivity (95% BCI) | Diagnostic specificity (95% BCI) | ||
|---|---|---|---|---|---|---|
Garcia et al. 2003[ Peru | 58.8 | Reversibleb | 0.889 (0.749–0.991) | 0.936 (0.925–0.946) | 0.207 (0.147–0.318) | 0.042 (0.004–0.124) |
Jayashi et al.[ Peru | 45.2 | 0.104 (0.085–0.133) | 0.024 (0.004–0.049) | |||
Lescano et al. [ Peru | 26.2 | 0.247 (0.116–0.387) | 0.746 (0.280–0.986) | |||
Taico et al.[ Peru | 20.7 | 0.152 (0.063–0.269) | 0.692 (0.209–0.984) | |||
Sarti et al.[ Mexico | 5.3 | 0.001 (0.00006–0.007) | 0.63 (0.022–0.980) | |||
Rodriguez-Canul et al.[ Mexico | 23.02 | Simplec | 0.940 (0.806–0.990) | 0.790 (0.765–0.82) | 0.001 (0.0001–0.006) | NA |
Gottschalk et al.[ Brazil | 20.5 | Simplec | 0.349 (0.297–0.403) | 0.921 (0.868–0.963) | 0.078 (0.035–0.146) | NA |
Khaing et al.[ Myanmar | 15.9 | Simplec | 0.940 (0.888–0.973) | 0.958 (0.915–0.985) | 0.028 (0.015–0.040) | NA |
Parameter median posterior estimates are presented with 95% Bayesian credible intervals (95% BCI). Supplementary File Table S1 provides full (location, diagnostics) details of studies.
NA not applicable.
aDiagnostic sensitivity and specificity for the antibody lentil lectin-purified glycoprotein enzyme-linked immunoelectrotransfer blot (Ab LLGP-EITB) assay[38,39] were jointly fitted across datasets.
bBest-fitting model determined by DIC (jointly-fitted dataset).
cBest-fitting model determined by DIC (individually-fitted dataset).
Figure 2The relationship between antibody seroprevalence and pig age (in months) for each dataset. Antibody seroconversion (simple) or seroconversion with seroreversion (reversible) catalytic models for (a) individually-fitted datasets and (b) jointly-fitted datasets (single diagnostic sensitivity and specificity values estimated; dataset-specific λ and ρ estimates obtained), including 95% confidence intervals associated with observed antibody seroprevalence point estimates. Bayesian Markov chain Monte Carlo methods were used to fit the models to data, with the parameter posterior distributions used to construct predicted (all age) seroprevalence curves and associated 95% Bayesian credible intervals (BCIs). Best-fitting model selected by deviance information criterion (DIC); both models presented if difference between DIC < 2 (both models have similar support based on the data); a difference > 10 units indicates that the models are significantly different and therefore only superior fitting model (lowest DIC) is presented). The non-zero predicted seroprevalence at age 0 is due to less than 100% specificity for all tests. The 95% confidence intervals (95% CI) for age-seroprevalence data-points are calculated by the Clopper-Pearson exact method.
Seroprevalence and parameter estimates for the best-fit catalytic models fitted to each observed antigen age-seroprevalence dataset (ordered by decreasing all-age seroprevalence).
| Dataset, country | All-age observed sero-prevalence (%) | Best-fit catalytic model | Diagnostic sensitivity (95% BCI) | Diagnostic specificity (95% BCI) | ||
|---|---|---|---|---|---|---|
Carrique-Mas et al.[ Bolivia | 37.4 | Simplec | 0.488 (0.376–0.650) | 0.927 (0.907–0.949) | 0.254 (0.109–0.836) | NA |
Fèvre et al.[ Kenya | 18.8 | 0.042 (0.016–0.105) | NA | |||
Kungu et al.[ (urban) Uganda | 0.011 (0.0015–0.029) | NA | ||||
Kungu et al.[ (rural) Uganda | 0.003 (0.0004–0.011) | NA | ||||
Pondja et al.[ Mozambique | 32.6 | Reversiblec | 0.685 (0.552–0.815) | 0.970 (0.956–0.981) | 0.093 (0.067–0.143) | 0.009 (0.0005–0.042) |
Kungu et al.[ (urban) Uganda | 0.079 (0.020–0.186) | 0.677 (0.112–0.984) | ||||
Kungu et al.[ (rural) Uganda | 0.005 (0.0003–0.024) | 0.733 (0.122–0.988) | ||||
Parameter median posterior estimates are presented with 95% Bayesian credible intervals (95% BCI). Supplementary File Table S1 provides full (location, diagnostics) details of studies.
NA Not applicable.
aDiagnostic sensitivity and specificity for the HP10 antigen- enzyme-linked immunosorbent assay (Ag-ELISA) test[48] was jointly fitted across datasets.
bDiagnostic sensitivity and specificity for the B158/B60 Ag-ELISA[50] or commercial B158/B60 Ag-ELISA (apDia, Turnhout, Belgium) was jointly fitted across datasets.
cBest fitting model determined by DIC (jointly-fitted dataset).
Figure 3The relationship between antigen seroprevalence and pig age (in months) for (a) Carrique-Mas et al.[27] in Bolivia; Pondja et al.[51] in Mozambique; Fèvre et al.[49] in Kenya; and (b) Kungu et al.[37] in urban- and rural-production systems in Uganda. Viable Taenia solium metacestode infection acquisition models with (reversible) or without (simple) infection loss jointly-fitted to antigen seroprevalence datasets (single diagnostic sensitivity and specificity values estimated; dataset-specific λ and ρ estimates obtained) for (a) HP10 Ag-ELISA and (b) B158/B60 Ag-ELISA or commercial B158/B60 Ag-ELISA (apDia, Turnhout, Belgium), including 95% confidence intervals associated with observed antigen seroprevalence point estimates. Bayesian Markov chain Monte Carlo methods were used to fit the models to data, with the parameter posterior distributions used to construct predicted prevalence curves and associated 95% Bayesian credible intervals (BCI). Best-fitting model selected by deviance information criterion (DIC); both models presented if difference between DIC < 2 (both models have similar support based on the data); a difference > 10 units indicates that the models are significantly different and therefore only superior fitting model (lowest DIC) is presented). In Kungu et al.[37] (Uganda) model-predicted prevalence is presented based on the urban- and rural-stratified data. The non-zero predicted seroprevalence at age 0 is due to less than 100% specificity for all tests. The 95% confidence intervals (95% CI) for age-seroprevalence data-points are calculated by the Clopper-Pearson exact method.
Prevalence and parameter estimates for the best-fit catalytic models fitted to each observed necropsy age-prevalence dataset (ordered by decreasing all-age prevalence).
| Dataset, country | All-age observed prevalence (%) | Best-fit catalytic model | ||
|---|---|---|---|---|
de Aluja et al.[ Mexico | 32.7 | Reversiblea | 0.529 (0.245–0.896) | 0.700 (0.163–0.986) |
Sah et al.[ Nepal | 28.4 | Reversiblea | 0.276 (0.058–0.515) | 0.684 (0.133–0.980) |
Sasmal et al.[ India | 10.3 | Reversiblea | 0.097 (0.052–0.137) | 0.801 (0.418–0.986) |
Parameter estimates are summarized by the median and 95% Bayesian credible interval (95% BCI) of the posterior distribution. Supplementary File Table S1 provides full (location) details of the studies. Diagnostic sensitivity and specificity parameter estimates are not shown because fitting to uncertainty in necropsy diagnostic characteristics was not required (sensitivity and specificity were assumed to be 100%).
aBest fitting model determined by DIC (individually-fitted dataset).
Figure 4The relationship between necropsy prevalence and pig age (months) for each dataset. Viable Taenia solium metacestode infection acquisition models with (reversible) or without (simple) infection loss fitted to each necropsy age-prevalence dataset, including 95% confidence intervals associated with observed prevalence point estimates. Bayesian Markov chain Monte Carlo methods were used to fit the models to data, with the parameter posterior distributions used to construct predicted prevalence curves and associated 95% Bayesian credible intervals (BCI). Best-fitting model selected by deviance information criterion (DIC); both models presented if difference between DIC < 2 (both models have similar support based on the data); a difference > 10 units indicates that the models are significantly different and therefore only superior fitting model (lowest DIC) is presented). The 95% confidence intervals (95% CI) for age-prevalence data-points are calculated by the Clopper-Pearson exact method.
Figure 5Average time (months) until pigs become antibody seropositive/infected (1/λ), or remain antibody seropositive or infected (1/ρ) vs. overall (all age) prevalence (percent). The relationship between (a) the average time until pigs become antibody seropositive or infected (1/λ) and overall (all-age) prevalence, and (b) the average time pigs remain antibody seropositive or infected (1/ρ) and overall (all-age) prevalence. The plot is stratified by proposed endemicity levels defined as hypoendemic (0–9.99% all-age (sero)prevalence), mesoendemic (10–24.99% all-age (sero)prevalence) and hyperendemic (≥ 25% all-age (sero)prevalence). Only λ median estimates are presented where 1/λ (average duration of susceptibility in months) is less than life expectancy of pigs; horizontal (grey) dashed line represents maximum life expectancy of pigs: 15 years × 12 months = 180 months[47]. The y-axis is in log scale for both panels.